ReviewDrugs2022
Olverembatinib: First Approval.
Sohita DhillonPubMed ↗Publisher ↗
No numbers read from the abstract.
42 papers cite it
this paperpooled ittrialcites it
ReviewDrugs2022
Sohita DhillonPubMed ↗Publisher ↗
No numbers read from the abstract.